Angelo Agathanggelou

Author

University of Birmingham ORCID

Also Known As

A Agathanggelou, A. Agathanggelou, ANGELO AGATHANGGELOU, Agathanggelou, Angelo, Angelo Agathanggelou

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

University of Birmingham Cancer Research UK Heartlands Hospital Birmingham Children's Hospital Queen Elizabeth Hospital Birmingham

About

Angelo Agathanggelou is an author at University of Birmingham specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	2.1K
2	Cell Biology	11	11	1.4K
3	Immunology	5	5	299
4	Natural Sciences	1	1	402
5	Cellular Physiology	1	1	87

Angelo Agathanggelou

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions Michal Zimmermann, Olga Murina, Martin A.M. Reijns, Nature Natural SciencesGeneticsParp-trapping LesionsMolecular BiologyDna Replication	2018	402
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours Angelo Agathanggelou, Sofia Honorio, Donia Macartney‐Coxson, Oncogene Region 3P21.3MedicineOvarian TumoursPathologyCancer Cell Biology	2001	377
Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia Oliver Goodyear, Angelo Agathanggelou, Igor Novitzky‐Basso, Blood	2010	334
ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells Marwan Kwok, Nicholas Davies, Angelo Agathanggelou, Blood	2015	266
EPSTEIN-BARR VIRUS (EBV) INFECTION IN INFECTIOUS MONONUCLEOSIS: VIRUS LATENCY, REPLICATION AND PHENOTYPE OF EBV-INFECTED CELLS Gerald Niedobitek, Angelo Agathanggelou, Hermann Herbst, The Journal of Pathology	1997	216
Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. C. O. Morrissey, Alonso Martínez, Malgorzata Zatyka, PubMed Epigenetic InactivationPathologyCc-rcc Cell LinesCancer BiologyEpigenetics	2001	200
Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease Hermann Herbst, HD Foss, Jens Samol, Blood	1996	191
Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma Gerald Niedobitek, Angelo Agathanggelou, Martin Rowe, Blood	1995	145
RASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule Dynamics Ashraf Dallol, Angelo Agathanggelou, Sarah L. Fenton, Cancer Research	2004	143
Inhibition of Human Breast Carcinoma Growth by a Soluble Recombinant Human CD40 Ligand Akio Hirano, Dan L. Longo, Dennis D. Taub, Blood	1999	140

Page 1